Specific active immunotherapy for melanoma.
Publication
, Journal Article
Seigler, HF; Cox, E; Mutzner, F; Shepherd, L; Nicholson, E; Shingleton, WW
Published in: Ann Surg
September 1979
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Ann Surg
DOI
ISSN
0003-4932
Publication Date
September 1979
Volume
190
Issue
3
Start / End Page
366 / 372
Location
United States
Related Subject Headings
- Surgery
- Skin Neoplasms
- Prognosis
- Melanoma
- Male
- Immunotherapy
- Humans
- Female
- BCG Vaccine
- Actuarial Analysis
Citation
APA
Chicago
ICMJE
MLA
NLM
Seigler, H. F., Cox, E., Mutzner, F., Shepherd, L., Nicholson, E., & Shingleton, W. W. (1979). Specific active immunotherapy for melanoma. Ann Surg, 190(3), 366–372. https://doi.org/10.1097/00000658-197909000-00012
Seigler, H. F., E. Cox, F. Mutzner, L. Shepherd, E. Nicholson, and W. W. Shingleton. “Specific active immunotherapy for melanoma.” Ann Surg 190, no. 3 (September 1979): 366–72. https://doi.org/10.1097/00000658-197909000-00012.
Seigler HF, Cox E, Mutzner F, Shepherd L, Nicholson E, Shingleton WW. Specific active immunotherapy for melanoma. Ann Surg. 1979 Sep;190(3):366–72.
Seigler, H. F., et al. “Specific active immunotherapy for melanoma.” Ann Surg, vol. 190, no. 3, Sept. 1979, pp. 366–72. Pubmed, doi:10.1097/00000658-197909000-00012.
Seigler HF, Cox E, Mutzner F, Shepherd L, Nicholson E, Shingleton WW. Specific active immunotherapy for melanoma. Ann Surg. 1979 Sep;190(3):366–372.
Published In
Ann Surg
DOI
ISSN
0003-4932
Publication Date
September 1979
Volume
190
Issue
3
Start / End Page
366 / 372
Location
United States
Related Subject Headings
- Surgery
- Skin Neoplasms
- Prognosis
- Melanoma
- Male
- Immunotherapy
- Humans
- Female
- BCG Vaccine
- Actuarial Analysis